Posted on 23/03/2010 in Medical Company Financials Kimberly-Clark has outlined a number of business objectives which it will undertake in order to achieve constant growth up to 2015.
The company has updated its long-term global business plan, highlighting a sales growth of three to five per cent on an annual basis over the next five years as a primary financial objective.
It hopes to achieve this through the expansion of its product portfolio and by placing more emphasis on higher-margin segments, with medical devices highlighted as a promising market in this respect.
The firm also emphasised the importance of improving its efficiency by reducing costs in areas such as manufacturing and supply chain activities.
Thomas Falk, chairman and chief executive officer of Kimberly-Clark, said: "We firmly believe that successful execution of our global business plan will deliver long-term value for our shareholders."
Earlier this month, the firm was named as one of the world's top five corporate citizens by Corporate Responsibility Magazine in recognition of its improved human rights and environmental activities.Other news stories from 23/03/2010
Read more in the Zenopa News Archive
How this news is generated
|
